Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program

NCT ID: NCT03042728

Last Updated: 2019-01-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

229 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-07

Study Completion Date

2018-10-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study the investigators hypothesize that the presence of a Mayo Clinic certified therapy dog will provide additional benefits above typical therapy for patients suffering from fibromyalgia currently enrolled in the Mayo Clinic Fibromyalgia Program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The human animal bond refers an emotional relationship between animals and people. The purpose of this study is to evaluate whether the presence of a dog provide additional benefits above typical therapy for patients suffering from fibromyalgia and also to assess the emotional wellbeing state of the therapy dog.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fibromyalgia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dog interaction

Dog interaction will be received by patients in addition to usual care of fibromyalgia.

Group Type ACTIVE_COMPARATOR

Dog Interaction

Intervention Type BEHAVIORAL

A therapy dog will visit the patients.

Human Interaction

Human interaction will be received by patients in addition to usual care of fibromyalgia.

Group Type ACTIVE_COMPARATOR

Human Interaction

Intervention Type BEHAVIORAL

A human will visit the patients.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dog Interaction

A therapy dog will visit the patients.

Intervention Type BEHAVIORAL

Human Interaction

A human will visit the patients.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with Fibromyalgia at our Fibromyalgia Clinic
* Patients actively being seen at the Fibromyalgia Clinic
* Able and willing to give informed consent
* Able to speak English
* Able to complete questionnaires
* No fear or allergy of dogs

Exclusion Criteria

* Diagnoses of bipolar disorder, schizophrenia, or dementia
* Individuals who decline to participate in the study
* Individuals that are severely allergic to or fearful of dogs
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mayo Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Arya B. Mohabbat, M.D.

PI

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arya B Mohabbat

Role: PRINCIPAL_INVESTIGATOR

Mayo Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Clinic

Rochester, Minnesota, United States

Site Status

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16-006296

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Behavioral Treatment of Fibromyalgia
NCT00000398 COMPLETED PHASE2
Support, Health, and Fibromyalgia
NCT00000423 COMPLETED PHASE2